Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Fiziol Zh (1994) ; 60(1): 25-33, 2014.
Artigo em Ucraniano | MEDLINE | ID: mdl-24809171

RESUMO

The effects of several forms of plasminogen on the state of actin cytoskeleton of human platelets were studied. A ratio between various actin pools, which were detected by immunoblotting, was taken as indicator of platelet cytoskeleton reorganization. It was revealed that intact platelets contain globular (G) actin and membrane cortex (MC) actin in amounts that are 56 and 40% of filamentous (F) actin level, respectively. In both thrombin- and collagen-activated platelets, actin is almost entirely presented in F-form. Incubation of resting platelets with Lys-plasminogen causes elevation of MC-actin level up to 79% in respect to F-form content. In addition, Lys-plasminogen inhibits reorganization of actin cytoskeleton typical for activated platelets. In contrast to Lys-form, Glu-plasminogen affects neither platelet aggregation nor redistribution of actin pools. Thus, these data indicate that cytoskeletal structures of platelets are involved in realization of anti-aggregating effects of Lys-plasminogen.


Assuntos
Actinas/metabolismo , Plaquetas/efeitos dos fármacos , Citoesqueleto/efeitos dos fármacos , Fragmentos de Peptídeos/farmacologia , Plasminogênio/farmacologia , Agregação Plaquetária/efeitos dos fármacos , Plaquetas/metabolismo , Células Cultivadas , Citoesqueleto/metabolismo , Humanos , Fragmentos de Peptídeos/fisiologia , Plasminogênio/fisiologia , Agregação Plaquetária/fisiologia
2.
Ukr Biokhim Zh (1999) ; 85(4): 111-8, 2013.
Artigo em Ucraniano | MEDLINE | ID: mdl-24319981

RESUMO

The activity and content of plasminogen activator inhibitor-1 (PAI-1) are important indicators of pathological processes, because its content in plasma increases at acute myocardium infarction, tumor, diabetes mellitus, etc. The present work is dedicated to the development and optimization of the methods of PAI-1 activity definition, which can be used in clinical practice. We have proposed the modification of the method COATEST PAI with the usage of chromogenic substrate S2251. According to our modification, the cyanogen bromide fragments of human fibrinogen have been changed into bovine desAB-fibrin. We have also developed the method with the usage of fibrin films. In this method fibrin is used as a stimulator of activation reaction and as a substrate at the same time. Using fibrin, the native substrate of plasmin, we provide high specificity of the reaction and exclude the cross-reaction with other plasma enzymes.


Assuntos
Bioensaio , Inibidor 1 de Ativador de Plasminogênio/sangue , Animais , Bovinos , Brometo de Cianogênio/química , Fibrina/química , Fibrinogênio/química , Fibrinolisina/química , Humanos , Cinética , Plasminogênio/química , Ativador de Plasminogênio Tecidual/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...